Their study showed that GDNPs, through components such as ceramide lipids and proteins, potentially activate Toll-like receptor 4 (TLR4), leading to a significant reduction in melanoma growth in mice and an increase in M1 macrophages within tumor tissues 62. The gene discussed is TLR4; the disease is neoplasm.